Search - tctmd.com

Displaying 21 - 40 of 78

Sort: Relevancy | Date

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

Simple Sitting-Rising Test Linked to Natural and CV Mortality

L.A. McKeown

June 18, 2025

News Daily News

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

Caitlin E. Cox

June 13, 2025

News Daily News

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

Michael O'Riordan

June 10, 2025

News Daily News

FDA Approves Triple Therapy Polypill for High Blood Pressure

Michael O'Riordan

June 10, 2025

News Conference News ESOC 2025

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

Todd Neale

June 02, 2025

News Conference News EuroPCR 2025

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

Michael O'Riordan

May 29, 2025

News Conference News ESOC 2025

High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

Todd Neale

May 29, 2025

News Conference News European Congress on Obesity 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

Presentation Fellows 2025

Welcome and Symplicity RDN Blood Pressure Procedure

Presenter: Sahil A. Parikh

May 16, 2025

News Daily News

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

Caitlin E. Cox

May 15, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News European Congress on Obesity 2025

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

Michael O'Riordan

May 12, 2025

News Conference News SCAI 2025

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

L.A. McKeown

May 09, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

Caitlin E. Cox

May 08, 2025

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

Advertisement

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Simple Sitting-Rising Test Linked to Natural and CV Mortality

AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty

PREVENT Risk Calculator Works Well in Patients With High and Low Lp(a)

FDA Approves Triple Therapy Polypill for High Blood Pressure

Simple, Phone-Based Strategy Improves BP Control in Stroke Survivors

‘Quick and Sustained’ Bumps in HR and BP When Beta-blockers Stopped Post-MI

High Residual Risk of Recurrent Stroke Seen in AF Patients on Anticoagulants

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Welcome and Symplicity RDN Blood Pressure Procedure

Poor Cardiometabolic Health in Pregnancy Tied to Higher BP for Young Offspring

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Tirzepatide Tops Semaglutide for Weight Loss: SURMOUNT-5

When Early Cardiogenic Shock Isn’t Dealt With, Outcomes Can Suffer

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Conversion Therapy Tied to Worse CV Risk Factors in Sexual, Gender Minorities

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content